MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ABCL has $1,355,992K in assets. $391,954K in debts. $83,159K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1010.32%
Cash Ratio
120.86%
Debt to Asset Ratio
28.91%
Assets Breakdown
    • Property and equipment, net
    • Marketable securities
    • Other current assets
    • Others
Liabilities Breakdown
    • Common shares no par value, unli...
    • Additional paid-in capital
    • Deferred government contribution...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
83,159 92,437
Marketable securities
412,513 460,641
Total cash, cash equivalents, and marketable securities
495,672 553,078
Accounts and accrued receivable
41,456 47,310
Restricted cash
25,000 25,000
Other current assets
133,012 116,757
Total current assets
695,140 742,145
Property and equipment, net
427,358 424,020
Gross carrying amount
91,133 -
Accumulated amortization
51,812 -
Intangible assets, net
39,321 40,262
Goodwill
47,806 47,806
Investments in equity accounted investees
93,301 90,374
Other long-term assets
53,066 57,454
Total long-term assets
660,852 659,916
Total assets
1,355,992 1,402,061
Accounts payable and other current liabilities
53,117 50,074
Contingent consideration payable
0 0
Deferred revenue
15,687 16,949
Total current liabilities
68,804 67,023
Operating lease liability
137,052 137,184
Deferred revenue
5,850 11,633
Deferred government contributions
169,118 167,532
Deferred tax liability
9,744 10,053
Other long-term liabilities
1,386 1,560
Total long-term liabilities
323,150 327,962
Total liabilities
391,954 394,985
Common shares no par value, unlimited authorized shares at december31, 2024 and september30, 2025 295,757,002 and 299,011,566 shares issued and outstanding at december31, 2024 and september30, 2025, respectively
794,469 791,668
Additional paid-in capital
192,804 181,483
Accumulated other comprehensive loss
-2,698 -2,657
Accumulated earnings (deficit)
-20,537 36,582
Total shareholders' equity
964,038 1,007,076
Total liabilities and shareholders' equity
1,355,992 1,402,061
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Gross carrying amount$91,133K Marketable securities$412,513K Cash and cashequivalents$83,159K Other long-termassets$53,066K Investments in equityaccounted investees$93,301K Goodwill$47,806K Intangible assets, net$39,321K Property and equipment,net$427,358K Other current assets$133,012K Restricted cash$25,000K Accounts and accruedreceivable$41,456K Total cash, cashequivalents, and marketable...$495,672K Accumulated amortization$51,812K Total long-termassets$660,852K Total current assets$695,140K Total assets$1,355,992K Total liabilities andshareholders' equity$1,355,992K Total shareholders'equity$964,038K Total liabilities$391,954K Accumulated earnings(deficit)-$20,537K Accumulated othercomprehensive loss-$2,698K Additional paid-in capital$192,804K Common shares no parvalue, unlimited...$794,469K Total long-termliabilities$323,150K Total currentliabilities$68,804K Other long-termliabilities$1,386K Deferred tax liability$9,744K Deferred governmentcontributions$169,118K Deferred revenue$5,850K Operating lease liability$137,052K Deferred revenue$15,687K Accounts payable andother current...$53,117K

AbCellera Biologics Inc. (ABCL)

AbCellera Biologics Inc. (ABCL)